Immunotherapy and prostate cancer
To access this article, please choose from the options below
PII: S0305-7372(03)00005-7
doi:10.1016/S0305-7372(03)00005-7
© 2003 Elsevier Science Ltd. All rights reserved.
PII: S0305-7372(03)00005-7
doi:10.1016/S0305-7372(03)00005-7
© 2003 Elsevier Science Ltd. All rights reserved.